NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
Back to search
Official data from USPTO
PACBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
06/13/2023
Trademark type
Word
Nice classes
42
Filing date
10/17/2019
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-01-00
First use in commerce
03/16/2023
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
KHAN, AHSEN
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Phanes Therapeutics, Inc.
Representatives
Matthew R. Grothouse ICE MILLER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research and development activities relating theretoantibody research and design; Providing recombinant antibody technology platform in the nature of research and development of monospecificbispecific and multi-specific antibodies or fragments and the development of pharmaceutical products based on monospecificbispecific and multi-specific antibodies or fragments; Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical product development; product developability testingpharmaceutical antibody evaluation; development of pharmaceutical preparations and medicines; product design-based functionality testingconducting early evaluations in the field of new pharmaceuticals; medical and scientific researchconducting clinical trials for others; chemicalbiochemicalbiological and bacteriological research and analysis; biological research; scientific studyresearch and development in the fields of medicinethe preventiontreatment and management of illnesshealth care delivery; technology research in the field of pharmaceutical research and development; medical research; medical laboratories
Publications
History of USPTO decisions and trademark events.
56 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/10/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/06/2023
IUAF
USE AMENDMENT FILED
03/21/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/21/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/26/2022
EX4G
SOU EXTENSION 4 GRANTED
08/24/2022
EXT4
SOU EXTENSION 4 FILED
08/24/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/24/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2022
EX3G
SOU EXTENSION 3 GRANTED
03/28/2022
EXT3
SOU EXTENSION 3 FILED
03/28/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/13/2021
EX2G
SOU EXTENSION 2 GRANTED
07/09/2021
EXT2
SOU EXTENSION 2 FILED
07/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2021
EX1G
SOU EXTENSION 1 GRANTED
03/01/2021
EXT1
SOU EXTENSION 1 FILED
03/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/23/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/23/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/23/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/29/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/19/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/09/2020
PUBO
PUBLISHED FOR OPPOSITION
06/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/20/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2020
GNFR
FINAL REFUSAL E-MAILED
04/14/2020
CNFR
FINAL REFUSAL WRITTEN
04/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/23/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/23/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/23/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/23/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/23/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/28/2020
GNRT
NON-FINAL ACTION E-MAILED
01/28/2020
CNRT
NON-FINAL ACTION WRITTEN
01/28/2020
DOCK
ASSIGNED TO EXAMINER
01/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2019
NWAP
NEW APPLICATION ENTERED
10/21/2019
Continuous trademark protection
Get notified about every new filing that threatens PACBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.